Clinical Data ATS 2026: PABPC4 gene identified as a key driver of emphysema in COPD Pharmaceutical TechnologyPABPC4 genetic variants found to be associated with mitochondrial dysfunction driving emphysema in COPD.RespiratoryRead full story pharminent May 21, 2026 (Last updated: May 21, 2026) Pharmaceutical Technology PABPC4 genetic variants found to be associated with mitochondrial dysfunction driving emphysema in COPD. Respiratory Read full story Post navigation Previous: ATS 2026: Long-term data show durable benefit of Trikafta for cystic fibrosisNext: Bayer gets swift review for Kerendia in type 1 diabetes Related Stories Clinical Data Novo Nordisk starts trialing lower maintenance doses of oral Wegovy pharminent August 21, 2026 Clinical Data Cancer vaccine win restores Wall Street’s faith in Moderna pharminent August 20, 2026 Clinical Data New Taiho, Cullian data heats up lung cancer drug battle pharminent August 13, 2026
